DK1064279T3 - Substituerede bisindolylmaleimider til inhibering af celleproliferation - Google Patents

Substituerede bisindolylmaleimider til inhibering af celleproliferation

Info

Publication number
DK1064279T3
DK1064279T3 DK99915558T DK99915558T DK1064279T3 DK 1064279 T3 DK1064279 T3 DK 1064279T3 DK 99915558 T DK99915558 T DK 99915558T DK 99915558 T DK99915558 T DK 99915558T DK 1064279 T3 DK1064279 T3 DK 1064279T3
Authority
DK
Denmark
Prior art keywords
cell proliferation
inhibit cell
bisindolylmaleimides
substituted
substituted bisindolylmaleimides
Prior art date
Application number
DK99915558T
Other languages
Danish (da)
English (en)
Inventor
Donna Mary Huryn
Giuseppe Federico Weber
Urvashi Hooda Dhingra
June Ke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1064279T3 publication Critical patent/DK1064279T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99915558T 1998-03-17 1999-03-10 Substituerede bisindolylmaleimider til inhibering af celleproliferation DK1064279T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7833198P 1998-03-17 1998-03-17
PCT/EP1999/001534 WO1999047518A1 (en) 1998-03-17 1999-03-10 Substituted bisindolymaleimides for the inhibition of cell proliferation

Publications (1)

Publication Number Publication Date
DK1064279T3 true DK1064279T3 (da) 2003-10-06

Family

ID=22143350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99915558T DK1064279T3 (da) 1998-03-17 1999-03-10 Substituerede bisindolylmaleimider til inhibering af celleproliferation

Country Status (34)

Country Link
US (1) US6048887A (US06894165-20050517-C00155.png)
EP (1) EP1064279B1 (US06894165-20050517-C00155.png)
JP (2) JP5026633B2 (US06894165-20050517-C00155.png)
KR (1) KR100659411B1 (US06894165-20050517-C00155.png)
CN (1) CN1127500C (US06894165-20050517-C00155.png)
AR (1) AR018162A1 (US06894165-20050517-C00155.png)
AT (1) ATE243693T1 (US06894165-20050517-C00155.png)
AU (1) AU755673B2 (US06894165-20050517-C00155.png)
BR (1) BR9908882A (US06894165-20050517-C00155.png)
CA (1) CA2322689C (US06894165-20050517-C00155.png)
CO (1) CO5070675A1 (US06894165-20050517-C00155.png)
CZ (1) CZ299068B6 (US06894165-20050517-C00155.png)
DE (1) DE69909068T2 (US06894165-20050517-C00155.png)
DK (1) DK1064279T3 (US06894165-20050517-C00155.png)
ES (1) ES2203111T3 (US06894165-20050517-C00155.png)
HK (1) HK1036452A1 (US06894165-20050517-C00155.png)
HR (1) HRP20000585B1 (US06894165-20050517-C00155.png)
HU (1) HU228831B1 (US06894165-20050517-C00155.png)
ID (1) ID26353A (US06894165-20050517-C00155.png)
IL (1) IL138247A (US06894165-20050517-C00155.png)
MA (1) MA26613A1 (US06894165-20050517-C00155.png)
MY (1) MY121046A (US06894165-20050517-C00155.png)
NO (1) NO320306B1 (US06894165-20050517-C00155.png)
NZ (1) NZ506476A (US06894165-20050517-C00155.png)
PE (1) PE20000340A1 (US06894165-20050517-C00155.png)
PL (1) PL195323B1 (US06894165-20050517-C00155.png)
PT (1) PT1064279E (US06894165-20050517-C00155.png)
RS (1) RS49965B (US06894165-20050517-C00155.png)
RU (1) RU2208612C2 (US06894165-20050517-C00155.png)
SA (1) SA99191295B1 (US06894165-20050517-C00155.png)
TR (1) TR200002580T2 (US06894165-20050517-C00155.png)
TW (1) TW539676B (US06894165-20050517-C00155.png)
WO (1) WO1999047518A1 (US06894165-20050517-C00155.png)
ZA (1) ZA992072B (US06894165-20050517-C00155.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299068B6 (cs) * 1998-03-17 2008-04-16 F. Hoffmann-La Roche Ag Substituovaný bisindolylmaleinimid a farmaceutický prostredek s jeho obsahem
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
KR20020038817A (ko) * 1999-10-12 2002-05-23 프리돌린 클라우스너, 롤란드 비. 보레르 암 치료를 위한 항세포증식제로서의 치환 피롤
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
US6482847B2 (en) 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6469179B1 (en) 2000-10-03 2002-10-22 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6548531B2 (en) 2001-02-09 2003-04-15 Hoffmann-La Roche Inc. Method for cancer therapy
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
WO2008117935A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
CN102924437B (zh) * 2012-11-19 2014-07-02 东华大学 3-哌嗪基-4-吲哚马来酰亚胺化合物及其制备和应用
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK75289A3 (en) * 1988-02-10 1998-05-06 Hoffmann La Roche Substituted pyrroles, their use for producing a drug, and the drug on their base
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
SI0817627T1 (US06894165-20050517-C00155.png) * 1993-12-23 2005-08-31 Lilly Co Eli
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91698A1 (es) * 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
CZ299068B6 (cs) * 1998-03-17 2008-04-16 F. Hoffmann-La Roche Ag Substituovaný bisindolylmaleinimid a farmaceutický prostredek s jeho obsahem

Also Published As

Publication number Publication date
CZ299068B6 (cs) 2008-04-16
IL138247A0 (en) 2001-10-31
CN1127500C (zh) 2003-11-12
ATE243693T1 (de) 2003-07-15
MA26613A1 (fr) 2004-12-20
HU228831B1 (en) 2013-05-28
HUP0101258A3 (en) 2002-08-28
KR20010041995A (ko) 2001-05-25
PE20000340A1 (es) 2000-05-13
IL138247A (en) 2005-08-31
MY121046A (en) 2005-12-30
ZA992072B (en) 1999-09-22
EP1064279B1 (en) 2003-06-25
JP5026633B2 (ja) 2012-09-12
TR200002580T2 (tr) 2000-11-21
AR018162A1 (es) 2001-10-31
YU55200A (sh) 2002-11-15
NO320306B1 (no) 2005-11-21
HRP20000585B1 (en) 2009-02-28
AU3409999A (en) 1999-10-11
CO5070675A1 (es) 2001-08-28
US6048887A (en) 2000-04-11
DE69909068D1 (de) 2003-07-31
HK1036452A1 (en) 2002-01-04
CZ20003384A3 (cs) 2000-12-13
JP2002506864A (ja) 2002-03-05
NO20004579D0 (no) 2000-09-14
TW539676B (en) 2003-07-01
EP1064279A1 (en) 2001-01-03
WO1999047518A1 (en) 1999-09-23
HRP20000585A2 (en) 2001-08-31
HUP0101258A2 (hu) 2001-10-28
PL342964A1 (en) 2001-07-16
RU2208612C2 (ru) 2003-07-20
JP2010222366A (ja) 2010-10-07
NZ506476A (en) 2003-12-19
CN1293671A (zh) 2001-05-02
PT1064279E (pt) 2003-10-31
BR9908882A (pt) 2000-11-21
SA99191295B1 (ar) 2006-04-26
KR100659411B1 (ko) 2006-12-18
NO20004579L (no) 2000-09-14
ID26353A (id) 2000-12-14
CA2322689C (en) 2008-11-25
AU755673B2 (en) 2002-12-19
RS49965B (sr) 2008-09-29
DE69909068T2 (de) 2004-05-06
ES2203111T3 (es) 2004-04-01
CA2322689A1 (en) 1999-09-23
PL195323B1 (pl) 2007-09-28

Similar Documents

Publication Publication Date Title
DK0915872T3 (da) Substituerede bisindolylmaleimider til inhibering af celleproliferation
DE69940291D1 (de) Weltraumsolarzelle
DE19980447D2 (de) Solarzellenanordnung
DE10066271B8 (de) Solarzelle
DE69907918D1 (de) Solarzellen-BAUELEMENT
NO20006157D0 (no) Celleadhesjons-inhiberende anti-inflammatoriske forbindelser
DK1064279T3 (da) Substituerede bisindolylmaleimider til inhibering af celleproliferation
DE60143221D1 (de) Solarzelle
DE69941616D1 (de) Solarzelle
DK1351958T3 (da) Imidazol-5-yl-2-anilinopyrimidiner som midler til inhibering af celleproliferation
DK0915870T3 (da) Substituerede bisindolylmaleimider til bekæmpelse af celleprofileration
DK1181269T3 (da) Celleproliferationsinhibitorer
DE69926844D1 (de) Planare Lichtwellenschaltung
ATE347551T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE29819363U1 (de) Kompensator
DE50006021D1 (de) Brennstoffzellenblock
DE69920608D1 (de) Solarzellenbatterie
ID27048A (id) Metode untuk mencegah mrp1
NO20022776L (no) Substituerte bisindolylmaleimider for inhibering av celleproliferasjon
DE19983547T1 (de) Gefrierschutzmittel
DE29804095U1 (de) Niedrigenergiehaus
ID29804A (id) Komposisi tabir surya
ID28823A (id) Susunan sel mengapung
DK199800466U3 (da) Plastikdæksel til afdækning af stikkontakter
EE200000516A (et) Sideedastussüsteemide või nendega seotud täiustused